Purchases and Sales Made in Q4 2024 in Sc Pharmaceuticals Inc. (SCPH)
This table provides information about the institutional ownership of Sc Pharmaceuticals Inc. (SCPH) during Q4 2024. The information is specifically focused on institutions that hold shares of scPharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 04, 2025
Q4 2024
|
Ifp Advisors, Inc
|
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-17- 11.49% |
$53.4 - $77
|
131
$637
|
|
|
Feb 07, 2025
Q4 2024
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
SELL
|
- |
-61- 66.3% |
$192 - $276
|
31
$151
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-474- 11.89% |
$1.49K - $2.15K
|
3.51K
$17.1K
|
|
|
Jan 31, 2025
Q4 2024
|
Bfsg, LLC
|
SELL
|
- |
-500- 25.0% |
$1.57K - $2.27K
|
1.5K
$7.29K
|
|
|
Feb 04, 2025
Q4 2024
|
Cwm, LLC
|
SELL
|
- |
-669- 96.68% |
$2.1K - $3.03K
|
23
$112
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-2.15K- 72.65% |
$6.74K - $9.72K
|
808
$3.93K
|
|
|
Feb 11, 2025
Q4 2024
|
Perkins Capital Management Inc
|
SELL
|
- |
-4K- 24.69% |
$12.6K - $18.1K
|
12.2K
$59.3K
|
|
|
May 29, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-8.95K- 17.37% |
$28.1K - $40.5K
|
42.6K
$207K
|
|
|
Feb 10, 2025
Q4 2024
|
Thrivent Financial For Lutherans
Minneapolis, MN |
SELL
|
- |
-12.3K- 1.17% |
$38.5K - $55.6K
|
1.04M
$5.04M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-31.2K- 22.13% |
$98.1K - $141K
|
110K
$534K
|
|
|
Feb 10, 2025
Q4 2024
|
Tejara Capital LTD
London, X0 |
SELL
|
- |
-37.4K- 5.75% |
$117K - $169K
|
613K
$2.98M
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-37.6K- 26.88% |
$118K - $170K
|
102K
$497K
|
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-89.2K- 49.62% |
$280K - $404K
|
90.5K
$440K
|
|
|
Feb 13, 2025
Q4 2024
|
Stonepine Capital Management, LLC
Bend, OR |
SELL
|
- |
-95.3K- 12.24% |
$299K - $432K
|
684K
$3.32M
|
|
|
Feb 14, 2025
Q4 2024
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-161K- 11.66% |
$505K - $729K
|
1.22M
$5.92M
|
|
|
Feb 14, 2025
Q4 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-204K- 40.63% |
$640K - $923K
|
298K
$1.45M
|
|
|
Feb 14, 2025
Q4 2024
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-208K- 10.16% |
$653K - $943K
|
1.84M
$8.95M
|